INFLUENCE OF SERUM TRIGLYCERIDES ON THE HDL PATTERN IN NORMAL SUBJECTS AND PATIENTS WITH CORONARY-ARTERY DISEASE

被引:26
|
作者
CALABRESI, L [1 ]
FRANCESCHINI, G [1 ]
SIRTORI, M [1 ]
GIANFRANCESCHI, G [1 ]
WERBA, P [1 ]
SIRTORI, CR [1 ]
机构
[1] UNIV MILAN, CTR E GROSSI PAOLETTI, INST PHARMACOL SCI, VIA BALZARETTI 9, I-20133 MILAN, ITALY
关键词
Cholesterol esterification; Coronary artery disease; High density lipoprotein subfractions; Hypertriglyceridemia; Lipid transfers;
D O I
10.1016/0021-9150(90)90006-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The distribution and structure of high density lipoprotein (HDL) subfractions were examined by rate zonal ultracentrifugation in 200 consecutive subjects, 86 of whom showed a stable hypertriglyceridemia, 22 with coronary artery disease. Among the remaining 114 normotriglyceridemic subjects, 75 were healthy and 39 had coronary disease. The serum levels of the HDL2 subfraction were reduced by 22% in the 39 normotriglyceridemic coronary patients, and by 21% in the whole group of hypertriglyceridemic subjects. No difference in the HDL3 levels was found in any of the studied group. There was a clear negative correlation between HDL2 levels and triglyceridemia in the case of healthy people, not in coronary patients. By contrast, triglyceridemia was negatively correlated with the HDL3flotation rate, both in healthy subjects and coronary patients at all triglyceride levels. Compositional data indicate that in hypertriglyceridemic subjects, HDL2 levels are reduced because of an enhanced transfer-exchanged process between the enlarged VLDL pool and HDL; in contrast, in coronary patients, a defective maturation of the HDL3 particle is the most likely underlying mechanism. Both in hypertriglyceridemic individuals, as well as in coronary patients, the HDL subfraction distribution is rather similar and drastically different from that of normotriglyceridemic healthy subjects. The mechanisms of the two conditions are probably different and, whereas a low concentration of HDL2 is definitely a major risk factor for normotriglyceridemic individuals, in the case of hypertriglyceridemics other factors may come into play in the final determination of the coronary risk. © 1990.
引用
收藏
页码:41 / 48
页数:8
相关论文
共 50 条
  • [1] INFLUENCE OF PLASMA TRIGLYCERIDES ON LIPOPROTEIN PATTERNS IN NORMAL SUBJECTS AND IN PATIENTS WITH CORONARY-ARTERY DISEASE
    RICHARDS, EG
    GRUNDY, SM
    COOPER, K
    AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (17): : 1214 - 1220
  • [2] HDL AND CORONARY-ARTERY DISEASE
    TRIBBLE, DL
    KRAUSS, RM
    ADVANCES IN INTERNAL MEDICINE, VOLUME 38, 1993, 38 : 1 - 29
  • [3] SERUM TRIGLYCERIDES IN THE PREDICTION OF CORONARY-ARTERY DISEASE (AN ITALIAN EXPERIENCE)
    MENOTTI, A
    SCANGA, M
    MORISI, G
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (01): : 29 - 32
  • [4] PLATELET ACTIVATION BY MENTAL STRESS IN NORMAL SUBJECTS AND IN PATIENTS WITH CORONARY-ARTERY DISEASE
    GRIGNANI, G
    PACCHIARINI, L
    ZUCCHELA, M
    TACCONI, F
    CANEVARI, A
    SOFFIANTINO, F
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 992 - 992
  • [5] DIASTOLIC MITRAL ANNULAR MOTION IN NORMAL SUBJECTS AND PATIENTS WITH CORONARY-ARTERY DISEASE
    OHTE, N
    NARITA, H
    HASHIMOTO, T
    KOBAYASHI, K
    AKITA, S
    FUJINAMI, T
    EUROPEAN HEART JOURNAL, 1995, 16 (07) : 943 - 950
  • [6] SERUM TRIGLYCERIDES IN CORONARY ARTERY DISEASE
    ALBRINK, MJ
    MANN, EB
    BONDY, PK
    TRANSACTIONS OF THE ASSOCIATION OF AMERICAN PHYSICIANS, 1958, 71 : 162 - 173
  • [7] SERUM TRIGLYCERIDES IN CORONARY ARTERY DISEASE
    ALBRINK, MJ
    MAN, EB
    ARCHIVES OF INTERNAL MEDICINE, 1959, 103 (01) : 4 - 8
  • [8] TRIGLYCERIDES AS A RISK FACTOR IN CORONARY-ARTERY DISEASE
    LEVY, RI
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 224 (13): : 1770 - 1770
  • [9] CORONARY-ARTERY DISEASE - RAISED CHOLESTEROL OR TRIGLYCERIDES
    RIEMERSMA, RA
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1984, 5 (02) : 193 - 194
  • [10] VERAPAMIL KINETICS IN NORMAL SUBJECTS AND PATIENTS WITH CORONARY-ARTERY SPASM
    FREEDMAN, SB
    RICHMOND, DR
    ASHLEY, JJ
    KELLY, DT
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (05) : 644 - 652